Aripiprazole and Metabolite, Serum or Plasma
2007945
Ordering Recommendation
Therapeutic monitoring of aripiprazole (eg, Abilify).
Submit With Order
Mnemonic
ARIPIPRAZO
Methodology
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Sun, Wed
Reported
1-5 days
N/A
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Pre-dose (trough) draw - At steady state concentration.  
Collect
Plain red. Also acceptable: Lavender (EDTA), pink (K2EDTA).  
Specimen Preparation
Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Gel separator tubes, light blue (citrate), or yellow (SPS or ACD solution).  
Remarks
N/A  
Stability
Ambient: 2 weeks; Refrigerated: 2 weeks; Frozen: 2 weeks  
Reference Interval
Therapeutic Range Not well established
Total (Aripiprazole and Dehydroaripiprazole) 150-​500 ng/mL
Toxic range Not well established
Interpretive Data
Adverse effects to aripiprazole therapy may include headache, nausea, somnolence and blurred vision.

See Compliance Statement B: www.aruplab.com/CS
Note
CPT Code(s)
80299
Components
Component Test Code*Component Chart Name
2007946Aripiprazole Serum/Plasma
2007947Dehydroaripiprazole, Serum/Plasma
2007948Total Aripiprazole and Metabolite S/P
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Cross References
  • Abilify